Keith M. Gottesdiener
2018
In 2018, Keith M. Gottesdiener earned a total compensation of $3.5M as President and Chief Executive Officer, Director at RHYTHM PHARMACEUTICALS, a 130% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $278,035 |
|---|---|
| Option Awards | $2,756,250 |
| Salary | $505,519 |
| Total | $3,539,804 |
Gottesdiener received $2.8M in option awards, accounting for 78% of the total pay in 2018.
Gottesdiener also received $278K in non-equity incentive plan and $505.5K in salary.
Rankings
In 2018, Keith M. Gottesdiener's compensation ranked 3,207th out of 14,244 executives tracked by ExecPay. In other words, Gottesdiener earned more than 77.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,207 out of 14,244 | 78th |
Division Manufacturing | 1,192 out of 5,762 | 79th |
Major group Chemicals And Allied Products | 413 out of 2,125 | 81st |
Industry group Drugs | 341 out of 1,814 | 81st |
Industry Pharmaceutical Preparations | 262 out of 1,388 | 81st |
Source: SEC filing on April 30, 2019.
Gottesdiener's colleagues
We found two more compensation records of executives who worked with Keith M. Gottesdiener at RHYTHM PHARMACEUTICALS in 2018.